Ferring Launches 3 New Clinical Trials for Marketed Bladder Cancer Gene Therapy Adstiladrin
The 3 new clinical trials will take place in the United States and are intended to increase the amount of accumulated data supporting the use of Adstiladrin in NMIBC.
Around the Helix: Cell and Gene Therapy Company Updates – April 17, 2024
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
More Research is Needed to Provide Patients With Guidance on CAR-T Late Effects
Aimee C. Talleur, MD, a physician at St. Jude Children’s Research Hospital, discussed obstacles to understanding late effects of CAR-T.
A Closer Look at Pricing for Cell and Gene Therapy
Amar Kelkar, MD, a stem cell transplantation physician at the Dana-Farber Cancer Institute, discussed his research on the value of advanced therapeutics.
CGTLive®’s Weekly Rewind – April 12, 2024
Review top news and interview highlights from the week ending April 12, 2024.
Allogeneic CAR-T Yields Some Responses in Multiple Myeloma After Anti-BCMA Therapy
The best response was very good partial response in 3 of 5 participants.